Riskpilot← Back to searchSign inGet full accessSMITH & NEPHEW A/S
A/SActiveCVR 26020050Kay Fiskers Plads 9, 1.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200126 employees
Revenue 2024
DKK 39,8M
+6% vs 2023
EBITDA margin
15.9%
-4% vs 2023
Equity ratio
62.7%
Financial strength
Net profit 2024
DKK 5,3M
+7% vs 2023
| Revenue | DKK 39,8M | +6% |
| EBITDA | DKK 6,3M | -4% |
| Net profit | DKK 5,3M | +7% |
| Total assets | DKK 91,7M | +19% |
| Equity | DKK 57,5M | +10% |
| Employees | 26 | — |
Legal name
SMITH & NEPHEW A/S
CVR number
26020050
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
4. maj 2001
Share capital
DKK 6.250.000
Employees
26 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af bestyrelsens formand i forening med et andet medlem af bestyrelsen.
Company purpose
Selskabets formål er fabrikation og handel
Address
Kay Fiskers Plads 9, 1.
Phone
+4545806100
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 26.586 | 31.920 | 43.459 | 37.544 | 39.774 |
| Staff expenses | -23.392 | -26.711 | -36.172 | -30.858 | -33.434 |
| EBITDA | 2.877 | 5.167 | 6.915 | 6.632 | 6.340 |
| Depreciation & amort. | -2.049 | -2.037 | -2.652 | -1.066 | -1.012 |
| EBIT | 828 | 3.130 | 4.263 | 5.566 | 5.328 |
| Net financials | -135 | -72 | -540 | 906 | 1.595 |
| Profit before tax | 693 | 3.058 | 3.723 | 6.472 | 6.923 |
| Tax | 153 | 709 | 880 | 1.530 | 1.626 |
| Net profit | 540 | 2.349 | 2.843 | 4.942 | 5.297 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 56.314 | 67.680 | 73.787 | 77.134 | 91.691 |
| Equity | 42.050 | 44.399 | 47.242 | 52.184 | 57.481 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 14.264 | 23.281 | 26.545 | 24.950 | 34.210 |
| Total debt | 14.264 | 23.281 | 26.545 | 24.950 | 34.210 |
EBITDA margin
15.9%
This company
15.8%
Market median
+1% vs market
20202024
Equity ratio
62.7%
This company
38.2%
Market median
+64% vs market
20202024
Return on equity
9.2%
This company
18.4%
Market median
-50% vs market
20202024
Net profit margin
13.3%
This company
8.1%
Market median
+64% vs market
20202024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20202024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KR Management | Management | 2022 |
| Former (6) | ||
GJ Management | Management | 2011 – 2013 |
JB Management | Management | 2020 – 2022 |
BK Management | Management | 2013 – 2018 |
BP Management | Management | 2005 – 2011 |
GN Management | Management | 2018 – 2020 |
CC Chief Executive Officer | Chief Executive Officer | 2001 – 2005 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Former (17) | ||
| Board of Directors | 2005 – 2009 | |
| Board of Directors | 2022 – 2023 | |
| Chairman | 2004 – 2008 | |
| Board of Directors | 2001 – 2007 | |
| Board of Directors | 2009 – 2014 | |
| Board of Directors | 2020 – 2021 | |
| Chairman | 2023 – 2024 | |
| Chairman | 2020 – 2023 | |
| Board of Directors | 2023 – 2025 | |
| Board of Directors | 2016 – 2016 | |
| Chairman | 2001 – 2003 | |
| Board of Directors | 2017 – 2018 | |
| Chairman | 2009 – 2016 | |
| Board of Directors | 2016 – 2017 | |
| Board of Directors | 2018 – 2019 | |
| Chairman | 2016 – 2020 | |
| Board of Directors | 2014 – 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2005 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SMITH & NEPHEW A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kirstine Rylev Holm | Management | 0 companies |
| Graham John Oddell | Management | 0 companies |
| Jytte Birgit Madsen | Management | 0 companies |
| Birgit Kirstine Ölmestig | Management | 0 companies |
| Bo Peter Gnattingius | Management | 0 companies |
| Gary Neil Lancaster | Management | 0 companies |
| Carsten Christensen | Chief Executive Officer | 0 companies |
| Olav Østensjø | Board of Directors | 0 companies |
| Dennis Foldager | Board of Directors | 0 companies |
| Peter William Huntley | Chairman | 0 companies |
| Tue Ronald Toft | Board of Directors | 0 companies |
| Frederik Lundby-Ibfelt | Board of Directors | 0 companies |
| Gemma Elizabeth Mary Parsons | Board of Directors | 0 companies |
| Peter Engberg Simonsen | Board of Directors | 0 companies |
| Renata Monika Banasik | Chairman | 0 companies |
| Paul Imre Jakob Heiskanen | Chairman | 0 companies |
| Charlotte Wulff Sjøgreen | Board of Directors | 0 companies |
| Elaine Richardson | Board of Directors | 0 companies |
| James Malcolm Taylor | Chairman | 0 companies |
| Lokesh Motwani | Board of Directors | 0 companies |
| Victoria Anne Reuben | Board of Directors | 0 companies |
| Magdalena Jadwiga Malkamäki | Chairman | 0 companies |
| Rolf Håkan Davidsson | Chairman | 0 companies |
| Timothy John Allison | Board of Directors | 0 companies |
| Jørgen Mann Nielsen | Board of Directors | 0 companies |
| Anneli Diana Charlotte Dahl | Chairman | 0 companies |
| Victoria Anne Reuben | Board of Directors | 0 companies |